▶ 調査レポート

旅行者下痢治療の世界市場:薬物クラス別(経口補水療法(ORS)、下痢止め剤、抗生物質[アジスロマイシン、シプロフロキサシン、キノロン、リファキシミ]、ワクチン/予防薬、その他)、病原菌別(細菌[E.コリ、サルモネラSpp、その他]、ウイルス、原虫)、年齢別(大人、子供)、流通経路別(小売薬局、病院薬局、オンライン薬局)

• 英文タイトル:Traveler’s Diarrhea Treatment Market (Drug Class: Oral Rehydration Therapy (ORS), Antidiarrheal Agents, Antibiotics [Azithromycin, Ciprofloxacin, Quinolones, and Rifaximi], Vaccines/Prophylactics, and Others; Pathogen: Bacteria [E. Coli, Salmonella Spp, and Others], Viruses, and Protozoa; Age Group: Adults and Children; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。旅行者下痢治療の世界市場:薬物クラス別(経口補水療法(ORS)、下痢止め剤、抗生物質[アジスロマイシン、シプロフロキサシン、キノロン、リファキシミ]、ワクチン/予防薬、その他)、病原菌別(細菌[E.コリ、サルモネラSpp、その他]、ウイルス、原虫)、年齢別(大人、子供)、流通経路別(小売薬局、病院薬局、オンライン薬局) / Traveler’s Diarrhea Treatment Market (Drug Class: Oral Rehydration Therapy (ORS), Antidiarrheal Agents, Antibiotics [Azithromycin, Ciprofloxacin, Quinolones, and Rifaximi], Vaccines/Prophylactics, and Others; Pathogen: Bacteria [E. Coli, Salmonella Spp, and Others], Viruses, and Protozoa; Age Group: Adults and Children; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / D0JU09142資料のイメージです。• レポートコード:D0JU09142
• 出版社/出版日:Transparency Market Research / 2019年12月23日
• レポート形態:英文、PDF、240ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥782,325 (USD5,795)▷ お問い合わせ
  Multi User¥1,187,325 (USD8,795)▷ お問い合わせ
  Corporate License¥1,592,325 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、旅行者下痢治療の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、市場概要、薬物クラス別(経口補水療法(ORS)、下痢止め剤、抗生物質[アジスロマイシン、シプロフロキサシン、キノロン、リファキシミ]、ワクチン/予防薬、その他)分析、病原菌別(細菌[E.コリ、サルモネラSpp、その他]、ウイルス、原虫)分析、年齢別(大人、子供)分析、流通経路別(小売薬局、病院薬局、オンライン薬局)分析、地域別分析、競争状況などの構成でお届けいたします。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場動向
・市場概要
・旅行者下痢治療の世界市場:薬物クラス別(経口補水療法(ORS)、下痢止め剤、抗生物質[アジスロマイシン、シプロフロキサシン、キノロン、リファキシミ]、ワクチン/予防薬、その他)
・旅行者下痢治療の世界市場:病原菌別(細菌[E.コリ、サルモネラSpp、その他]、ウイルス、原虫)
・旅行者下痢治療の世界市場:年齢別(大人、子供)
・旅行者下痢治療の世界市場:流通経路別(小売薬局、病院薬局、オンライン薬局)
・旅行者下痢治療の世界市場:地域別
・競争状況

Traveler’s Diarrhea Treatment Market – Scope of the Report

TMR’s report on the traveler’s diarrhea treatment market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the market during the forecast period from 2019 to 2027. The report provides the overall revenue of the traveler’s diarrhea treatment market for the period from 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the traveler’s diarrhea treatment market during the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global traveler’s diarrhea treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global traveler’s diarrhea treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global traveler’s diarrhea treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global traveler’s diarrhea treatment market.

The report delves into the competitive landscape of the global traveler’s diarrhea treatment market. Key players operating in the global traveler’s diarrhea treatment market are identified, and each one of them is profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global traveler’s diarrhea treatment market that have been profiled in this report.

Key Questions Answered in the Traveler’s Diarrhea Treatment Market Report

What is the scope of growth of product companies in the traveler’s diarrhea treatment market?
What will be the Y-o-Y growth of the traveler’s diarrhea treatment market between 2019 and 2027?
What is the influence of changing trends in technologies on the global traveler’s diarrhea treatment market?
Will North America continue to be the most profitable regional market for traveler’s diarrhea treatment product providers?
Which factors will impede the growth of the traveler’s diarrhea treatment market during the forecast period?
Which are the leading companies in the global traveler’s diarrhea treatment market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global traveler’s diarrhea treatment market, and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the production of the global traveler’s diarrhea treatment market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the traveler’s diarrhea treatment market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from traveler’s diarrhea treatment market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global traveler’s diarrhea treatment market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global traveler’s diarrhea treatment market more reliably and accurately.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Traveler’s Diarrhea Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Drug Class Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.1.1. Surge in Number of Travelers

4.3.1.2. Awareness Among Travelers

4.3.1.3. Evolution of Pathogens and Antimicrobial Resistance

4.3.1.4. Rise in Number of Food Contamination Cases

4.3.1.5. New Therapeutics in Development

4.3.2. Restraints

4.3.2.1. Trend of Self-medication Using OTC Products and Misuse of Antibiotics

4.3.2.2. Awareness about Hygiene

4.3.2.3. Introduction of Generic Products

4.3.3. Opportunities

4.4. Global Traveler’s Diarrhea Treatment Market Analysis and Forecasts, 2017–2027

5. Market Outlook

5.1. Overview of Guidelines for Diagnosis & Treatment of Traveler’s Diarrhea

5.2. Private/Public Sector Drug Supply Chain by Region/Country

5.3. Pipeline Analysis

5.4. Epidemiology of Traveler’s Diarrhea by Region/Sub-region

5.5. Overview of Causes/Percentage of Bacteria, Viruses and Protozoa Causing Traveler’s Diarrhea

6. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Drug Class

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class, 2017–2027

6.3.1. Oral Rehydration Therapy (ORS)

6.3.2. Antidiarrheal Agents

6.3.2.1. Antibiotics

6.3.2.2. Azithromycin

6.3.2.3. Ciprofloxacin

6.3.2.4. Quinolones

6.3.2.5. Rifaximin

6.3.3. Vaccines/prophylactics

6.3.4. Others

6.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Drug Class

7. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Pathogen

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027

7.3.1. Bacteria

7.3.1.1. E. Coli

7.3.1.2. Salmonella Spp

7.3.1.3. Others

7.3.2. Viruses

7.3.3. Protozoa

7.3.3.1. Giardiasis

7.3.3.2. Cryptosporidium parvum

7.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Pathogen

8. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Age

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027

8.3.1. Adults

8.3.2. Children

8.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Age

9. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Distribution Channel

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027

9.3.1. Retail Pharmacies

9.3.2. Hospital Pharmacies

9.3.3. Online Pharmacies

9.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Distribution Channel

10. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Region

11. North America Traveler’s Diarrhea Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027

11.2.1. Oral Rehydration Therapy (ORS)

11.2.2. Antidiarrheal Agents

11.2.3. Antibiotics

11.2.3.1. Azithromycin

11.2.3.2. Ciprofloxacin

11.2.3.3. Quinolones

11.2.3.4. Rifaximin

11.2.4. Vaccines/prophylactics

11.2.5. Others

11.3. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027

11.3.1. Bacteria

11.3.1.1. E. Coli

11.3.1.2. Salmonella Spp

11.3.1.3. Others

11.3.2. Viruses

11.3.3. Protozoa

11.3.3.1. Giardiasis

11.3.3.2. Cryptosporidium parvum

11.4. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027

11.4.1. Adults

11.4.2. Children

11.5. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027

11.5.1. Retail Pharmacies

11.5.2. Hospital Pharmacies

11.5.3. Online Pharmacies

11.6. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Country, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Traveler’s Diarrhea Treatment Market Attractiveness Analysis

11.7.1. By Drug Class

11.7.2. By Pathogen

11.7.3. By Age

11.7.4. By Distribution Channel

11.7.5. By Country

12. Europe Traveler’s Diarrhea Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027

12.2.1. Oral Rehydration Therapy (ORS)

12.2.2. Antidiarrheal Agents

12.2.3. Antibiotics

12.2.3.1. Azithromycin

12.2.3.2. Ciprofloxacin

12.2.3.3. Quinolones

12.2.3.4. Rifaximin

12.2.4. Vaccines/prophylactics

12.2.5. Others

12.3. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027

12.3.1. Bacteria

12.3.1.1. E. Coli

12.3.1.2. Salmonella Spp

12.3.1.3. Others

12.3.2. Viruses

12.3.3. Protozoa

12.3.3.1. Giardiasis

12.3.3.2. Cryptosporidium parvum

12.4. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027

12.4.1. Adults

12.4.2. Children

12.5. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027

12.5.1. Retail Pharmacies

12.5.2. Hospital Pharmacies

12.5.3. Online Pharmacies

12.6. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Traveler’s Diarrhea Treatment Market Attractiveness Analysis

12.7.1. By Drug Class

12.7.2. By Pathogen

12.7.3. By Age

12.7.4. By Distribution Channel

12.7.5. By Country/Sub-region

13. Asia Pacific Traveler’s Diarrhea Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class, 2017–2027

13.2.1. Oral Rehydration Therapy (ORS)

13.2.2. Antidiarrheal Agents

13.2.3. Antibiotics

13.2.3.1. Azithromycin

13.2.3.2. Ciprofloxacin

13.2.3.3. Quinolones

13.2.3.4. Rifaximin

13.2.4. Vaccines/prophylactics

13.2.5. Others

13.3. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027

13.3.1. Bacteria

13.3.1.1. E. Coli

13.3.1.2. Salmonella Spp

13.3.1.3. Others

13.3.2. Viruses

13.3.3. Protozoa

13.3.3.1. Giardiasis

13.3.3.2. Cryptosporidium parvum

13.4. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027

13.4.1. Adults

13.4.2. Children

13.5. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027

13.5.1. Retail Pharmacies

13.5.2. Hospital Pharmacies

13.5.3. Online Pharmacies

13.6. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Traveler’s Diarrhea Treatment Market Attractiveness Analysis

13.7.1. By Drug Class

13.7.2. By Pathogen

13.7.3. By Age

13.7.4. By Distribution Channel

13.7.5. By Country/Sub-region

14. Latin America Traveler’s Diarrhea Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Latin America Traveler’s Diarrhea Market Value Forecast, by Drug Class , 2017–2027

14.2.1. Oral Rehydration Therapy (ORS)

14.2.2. Antidiarrheal Agents

14.2.3. Antibiotics

14.2.3.1. Azithromycin

14.2.3.2. Ciprofloxacin

14.2.3.3. Quinolones

14.2.3.4. Rifaximin

14.2.4. Vaccines/prophylactics

14.2.5. Others

14.3. Latin America Traveler’s Diarrhea Market Value Forecast, by Pathogen, 2017–2027

14.3.1. Bacteria

14.3.1.1. E. Coli

14.3.1.2. Salmonella Spp

14.3.1.3. Others

14.3.2. Viruses

14.3.3. Protozoa

14.3.3.1. Giardiasis

14.3.3.2. Cryptosporidium parvum

14.4. Latin America Traveler’s Diarrhea Market Value Forecast, by Age, 2017–2027

14.4.1. Adults

14.4.2. Children

14.5. Latin America Traveler’s Diarrhea Market Value Forecast, by Distribution Channel, 2017–2027

14.5.1. Retail Pharmacies

14.5.2. Hospital Pharmacies

14.5.3. Online Pharmacies

14.6. Latin America Traveler’s Diarrhea Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Traveler’s Diarrhea Market Attractiveness Analysis

14.7.1. By Drug Class

14.7.2. By Pathogen

14.7.3. By Age

14.7.4. By Distribution Channel

14.7.5. By Country/Sub-region

15. Middle East & Africa Traveler’s Diarrhea Treatment Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027

15.2.1. Oral Rehydration Therapy (ORS)

15.2.2. Antidiarrheal Agents

15.2.3. Antibiotics

15.2.3.1. Azithromycin

15.2.3.2. Ciprofloxacin

15.2.3.3. Quinolones

15.2.3.4. Rifaximin

15.2.4. Vaccines/prophylactics

15.2.5. Others

15.3. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027

15.3.1. Bacteria

15.3.1.1. E. Coli

15.3.1.2. Salmonella Spp

15.3.1.3. Others

15.3.2. Viruses

15.3.3. Protozoa

15.3.3.1. Giardiasis

15.3.3.2. Cryptosporidium parvum

15.4. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027

15.4.1. Adults

15.4.2. Children

15.5. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027

15.5.1. Retail Pharmacies

15.5.2. Hospital Pharmacies

15.5.3. Online Pharmacies

15.6. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa Traveler’s Diarrhea Treatment Market Attractiveness Analysis

15.7.1. By Drug Class

15.7.2. By Pathogen

15.7.3. By Age

15.7.4. By Distribution Channel

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player – Competition Matrix (By Tier and Size of companies)

16.2. Market Share Analysis/Ranking By Company (2018)

16.3. Company Profiles

16.3.1. Johnson & Johnson (Johnson & Johnson Consumer Inc.)

16.3.1.1. Company Overview

16.3.1.2. Company Financials

16.3.1.3. Growth Strategies

16.3.1.4. SWOT Analysis

16.3.2. Bausch Health Companies Inc. (Salix Pharmaceuticals)

16.3.2.1. Company Overview

16.3.2.2. Company Financials

16.3.2.3. Growth Strategies

16.3.2.4. SWOT Analysis

16.3.3. COSMO PHARMACEUTICALS

16.3.3.1. Company Overview

16.3.3.2. Company Financials

16.3.3.3. Growth Strategies

16.3.3.4. SWOT Analysis

16.3.4. Immuron

16.3.4.1. Company Overview

16.3.4.2. Company Financials

16.3.4.3. Growth Strategies

16.3.4.4. SWOT Analysis

16.3.5. Valneva SE

16.3.5.1. Company Overview

16.3.5.2. Company Financials

16.3.5.3. Growth Strategies

16.3.5.4. SWOT Analysis

16.3.6. Sun Pharmaceutical Industries Ltd.

16.3.6.1. Company Overview

16.3.6.2. Company Financials

16.3.6.3. Growth Strategies

16.3.6.4. SWOT Analysis

16.3.7. Norgine

16.3.7.1. Company Overview

16.3.7.2. Company Financials

16.3.7.3. Growth Strategies

16.3.7.4. SWOT Analysis

16.3.8. Perrigo Company plc

16.3.8.1. Company Overview

16.3.8.2. Company Financials

16.3.8.3. Growth Strategies

16.3.8.4. SWOT Analysis

16.3.9. Bayer AG

16.3.9.1. Company Overview

16.3.9.2. Company Financials

16.3.9.3. SWOT Analysis

List of Tables

Table 01: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 03: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 04: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 05: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: North America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 08: North America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 09: North America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 10: North America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 11: Europe Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12: Europe Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 13: Europe Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 14: Europe Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 15: Europe Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 16: Asia Pacific Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Asia Pacific Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 18: Asia Pacific Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 19: Asia Pacific Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 20: Asia Pacific Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 21: Latin America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Latin America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 23: Latin America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 24: Latin America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 25: Latin America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 26: Middle East & Africa Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 27: Middle East & Africa Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 28: Middle East & Africa Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 29: Middle East & Africa Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 30: Middle East & Africa Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027